Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks

David S. Knopman, Joel S. Perlmutter

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)545-547
Number of pages3
JournalNeurology
Volume97
Issue number11
DOIs
StatePublished - Sep 14 2021

ASJC Scopus subject areas

  • Clinical Neurology

Cite this